Have Diagnostics, Therapies, and Vaccines Made the Difference in the Pandemic Evolution of COVID-19 in Comparison with "Spanish Flu"?

COVID-19 SARS-CoV-2 Spanish flu coronavirus influenza virus pandemic vaccines

Journal

Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317

Informations de publication

Date de publication:
23 Jun 2023
Historique:
received: 26 04 2023
revised: 15 06 2023
accepted: 21 06 2023
medline: 29 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

In 1918 many countries, but not Spain, were fighting World War I. Spanish press could report about the diffusion and severity of a new infection without censorship for the first-time, so that this pandemic is commonly defined as "Spanish flu", even though Spain was not its place of origin. "Spanish flu" was one of the deadliest pandemics in history and has been frequently compared with the coronavirus disease (COVID)-19 pandemic. These pandemics share similarities, being both caused by highly variable and transmissible respiratory RNA viruses, and diversity, represented by diagnostics, therapies, and especially vaccines, which were made rapidly available for COVID-19, but not for "Spanish flu". Most comparison studies have been carried out in the first period of COVID-19, when these resources were either not yet available or their use had not long started. Conversely, we wanted to analyze the role that the advanced diagnostics, anti-viral agents, including monoclonal antibodies, and innovative COVID-19 vaccines, may have had in the pandemic containment. Early diagnosis, therapies, and anti-COVID-19 vaccines have markedly reduced the pandemic severity and mortality, thus preventing the collapse of the public health services. However, their influence on the reduction of infections and re-infections, thus on the transition from pandemic to endemic condition, appears to be of minor relevance. The high viral variability of influenza and coronavirus may probably be contained by the development of universal vaccines, which are not easy to be obtained. The only effective weapon still remains the disease prevention, to be achieved with the reduction of promiscuity between the animal reservoirs of these zoonotic diseases and humans.

Identifiants

pubmed: 37513715
pii: pathogens12070868
doi: 10.3390/pathogens12070868
pmc: PMC10384375
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Déclaration de conflit d'intérêts

The text contains the personal opinion of the Authors, not of their Institutions. The authors declare no conflict of interest.

Références

Int J Biol Macromol. 2021 Mar 1;172:524-541
pubmed: 33454328
Ann Intern Med. 2006 Oct 17;145(8):599-609
pubmed: 16940336
Lancet Rheumatol. 2021 Apr;3(4):e241-e243
pubmed: 33655220
J Infect Dis. 2010 Dec 1;202(11):1639-48
pubmed: 21028954
Nature. 2023 May;617(7961):592-598
pubmed: 37011668
JAMA Intern Med. 2021 Oct 1;181(10):1343-1350
pubmed: 34424260
Vaccines (Basel). 2022 Oct 17;10(10):
pubmed: 36298596
J Exp Med. 1937 Jan 31;65(2):251-9
pubmed: 19870599
Proc Natl Acad Sci U S A. 2009 May 12;106(19):7962-7
pubmed: 19416838
J Infect Dis. 2022 Aug 24;226(2):195-198
pubmed: 35356987
N Engl J Med. 2009 Jul 16;361(3):225-9
pubmed: 19564629
J Clin Invest. 2020 Jun 1;130(6):2757-2765
pubmed: 32254064
Nature. 2023 Feb;614(7948):521-529
pubmed: 36535326
J Dev Orig Health Dis. 2010 Feb;1(1):26-34
pubmed: 20198106
Nat Med. 2022 May;28(5):1063-1071
pubmed: 35189624
J Hist Med Allied Sci. 2009 Oct;64(4):401-28
pubmed: 19525296
Int J Infect Dis. 2020 Sep;98:67-70
pubmed: 32599281
Nat Med. 2020 Nov;26(11):1708-1713
pubmed: 32934372
Lancet Infect Dis. 2023 May;23(5):556-567
pubmed: 36681084
Cell. 2022 Feb 3;185(3):447-456.e11
pubmed: 35026151
J Clin Virol. 2020 Jul;128:104412
pubmed: 32416600
mBio. 2021 Dec 21;12(6):e0196621
pubmed: 34872345
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Science. 2022 Nov 25;378(6622):899-904
pubmed: 36423275
N Engl J Med. 2023 Feb 9;388(6):565-567
pubmed: 36630611
Lancet. 2022 Feb 19;399(10326):757-768
pubmed: 34942102
Nature. 2022 Feb;602(7898):664-670
pubmed: 35016195
Bull World Health Organ. 2020 Jul 01;98(7):495-504
pubmed: 32742035
Nat Immunol. 2007 Nov;8(11):1188-93
pubmed: 17952044
Nature. 2022 Jun;606(7914):576-584
pubmed: 35385861
Am J Public Health (N Y). 1918 Oct;8(10):741-4
pubmed: 18009960
Nat Microbiol. 2020 Oct;5(10):1185-1191
pubmed: 32908214
Am J Public Health. 2021 Jul;111(7):1267-1272
pubmed: 34111372
Biomedicines. 2022 Aug 22;10(8):
pubmed: 36009598
Front Microbiol. 2022 Aug 10;13:932408
pubmed: 36033843
Cochrane Database Syst Rev. 2022 Jun 17;6:CD014945
pubmed: 35713300
JCI Insight. 2021 May 10;6(9):
pubmed: 33822773
NPJ Vaccines. 2022 Dec 19;7(1):167
pubmed: 36535982
Emerg Microbes Infect. 2021 Dec;10(1):1191-1199
pubmed: 34049471
Cureus. 2022 Jul 28;14(7):e27398
pubmed: 36046297
Stem Cell Rev Rep. 2021 Feb;17(1):9-32
pubmed: 32789802
Nat Rev Immunol. 2023 May;23(5):304-316
pubmed: 36539527
Biomedicines. 2022 Aug 02;10(8):
pubmed: 36009408
PLoS Pathog. 2013;9(7):e1003467
pubmed: 23853589
Front Cell Infect Microbiol. 2021 Apr 12;11:644574
pubmed: 33912475
Science. 2022 Nov 11;378(6620):619-627
pubmed: 36264829
BMC Med Genomics. 2022 Mar 18;15(1):62
pubmed: 35303887
N Engl J Med. 2023 Feb 9;388(6):567-569
pubmed: 36630643
Nat Rev Microbiol. 2011 Jul 04;9(8):617-26
pubmed: 21725337
Postgrad Med J. 2021 May;97(1147):273-274
pubmed: 33563705
Vaccines (Basel). 2021 Sep 17;9(9):
pubmed: 34579269
Emerg Infect Dis. 2006 Jan;12(1):15-22
pubmed: 16494711
N Engl J Med. 2023 Mar 23;388(12):1139-1141
pubmed: 36947471
J Zhejiang Univ Sci B. 2021 Feb 15;22(2):87-98
pubmed: 33615750
Nat Med. 2005 Apr;11(4 Suppl):S54-62
pubmed: 15812491
Mil Med Res. 2021 Jan 25;8(1):8
pubmed: 33487173
N Engl J Med. 2023 Feb 9;388(6):481-483
pubmed: 36630616
Emerg Infect Dis. 2010 Jun;16(6):1023-4
pubmed: 20507764
Proc Natl Acad Sci U S A. 2022 Mar 1;119(9):
pubmed: 35165203
Lancet Infect Dis. 2023 Apr;23(4):421-434
pubmed: 36521506
Viruses. 2022 Jul 30;14(8):
pubmed: 36016306
J Infect Dis. 2020 Jun 16;222(1):38-43
pubmed: 32348485
Science. 2022 Jan 14;375(6577):183-192
pubmed: 34855510
Front Microbiol. 2022 Jun 20;13:908525
pubmed: 35794916
Cell. 2022 Mar 3;185(5):847-859.e11
pubmed: 35139340
Viruses. 2019 Apr 16;11(4):
pubmed: 31014029
Microorganisms. 2021 Jan 07;9(1):
pubmed: 33430200
J Gen Virol. 2003 Sep;84(Pt 9):2285-2292
pubmed: 12917448
Nat Med. 2004 Dec;10(12 Suppl):S70-6
pubmed: 15577934
Presse Med. 2022 Sep;51(3):104127
pubmed: 35661699
Lancet Infect Dis. 2020 Apr;20(4):398-400
pubmed: 32113510
PLoS Pathog. 2013;9(10):e1003657
pubmed: 24130481
BMC Infect Dis. 2022 Sep 19;22(1):742
pubmed: 36123623
Pathogens. 2023 Jan 21;12(2):
pubmed: 36839441
Cell Rep Med. 2020 May 19;1(2):100016
pubmed: 32562483
Lancet. 2023 Mar 11;401(10379):833-842
pubmed: 36930674
BMC Infect Dis. 2019 Feb 06;19(1):117
pubmed: 30727970
JAMA Health Forum. 2023 Mar 3;4(3):e230046
pubmed: 36930169
Nature. 2022 Mar;603(7901):493-496
pubmed: 35102312
Front Immunol. 2022 Jul 26;13:834098
pubmed: 35958548
J Clin Invest. 2023 Mar 15;133(6):
pubmed: 36727404
Nat Rev Immunol. 2021 Nov;21(11):718-738
pubmed: 33981085
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496
pubmed: 32253318
Clin Infect Dis. 2014 Feb;58(3):319-27
pubmed: 24235265
BMC Infect Dis. 2022 Nov 5;22(1):816
pubmed: 36335289
Virology. 2019 Jan 15;527:32-37
pubmed: 30453209
Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16416-21
pubmed: 21930918
Nat Commun. 2023 May 12;14(1):2751
pubmed: 37173311
J Exp Med. 1940 Nov 30;72(6):729-45
pubmed: 19871057
Nature. 1998 Jul 30;394(6692):482-5
pubmed: 9697771
Neurosci Biobehav Rev. 2022 Nov;142:104902
pubmed: 36202253
Hum Vaccin Immunother. 2019;15(9):2009-2012
pubmed: 31121112
Front Med (Lausanne). 2020 Dec 03;7:594495
pubmed: 33344479
Lancet Infect Dis. 2020 Sep;20(9):e238-e244
pubmed: 32628905
Front Immunol. 2022 Jun 15;13:918611
pubmed: 35774782
Lancet Infect Dis. 2021 Apr;21(4):e77
pubmed: 32795407
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Science. 2022 Aug 19;377(6608):821-822
pubmed: 35981045
Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):7712-8
pubmed: 9223253
Nat Rev Microbiol. 2023 Mar;21(3):162-177
pubmed: 36653446
N Engl J Med. 2021 Feb 18;384(7):619-629
pubmed: 33232588
N Engl J Med. 2009 Jul 16;361(3):279-85
pubmed: 19564632
Nat Rev Microbiol. 2023 Mar;21(3):133-146
pubmed: 36639608
Cell Discov. 2021 Apr 13;7(1):24
pubmed: 33850112
Lancet Microbe. 2022 Jul;3(7):e471
pubmed: 35779561
Cell Death Differ. 2022 Oct;29(10):1891-1900
pubmed: 36071155
Nat Rev Microbiol. 2022 Apr;20(4):187-188
pubmed: 35181769
J Transl Med. 2020 Dec 22;18(1):489
pubmed: 33353549
Lancet Infect Dis. 2018 Oct;18(10):e323-e332
pubmed: 29754745
N Engl J Med. 2005 Nov 24;353(21):2209-11
pubmed: 16306515
Biomedicines. 2022 Aug 30;10(9):
pubmed: 36140226
J Exp Med. 1953 Dec;98(6):641-56
pubmed: 13109114
Clin Microbiol Infect. 2022 Sep;28(9):1230-1235
pubmed: 35545195
Signal Transduct Target Ther. 2020 Oct 6;5(1):219
pubmed: 33024082
J Prev Med Hyg. 2021 Sep 15;62(3):E613-E620
pubmed: 34909487
N Engl J Med. 2022 Apr 28;386(17):1661-1662
pubmed: 35417633
Bull Hist Med. 2002 Spring;76(1):105-15
pubmed: 11875246
J Infect Dis. 2008 Oct 1;198(7):962-70
pubmed: 18710327
PLoS Med. 2022 Sep 1;19(9):e1003992
pubmed: 36048766
J Virol. 2005 Sep;79(17):11533-6
pubmed: 16103207

Auteurs

Florigio Lista (F)

Istituto di Scienze Biomediche della Difesa, Ispettorato Generale della Sanità Militare, Stato Maggiore della Difesa, 00184 Roma, Italy.

Mario Stefano Peragallo (MS)

Centro Studi e Ricerche di Sanità e Veterinaria, Comando Logistico dell'Esercito, 00184 Roma, Italy.

Roberto Biselli (R)

Ispettorato Generale della Sanità Militare, Stato Maggiore della Difesa, 00184 Roma, Italy.

Riccardo De Santis (R)

Istituto di Scienze Biomediche della Difesa, Ispettorato Generale della Sanità Militare, Stato Maggiore della Difesa, 00184 Roma, Italy.
Dipartimento di Sanità Pubblica e Malattie Infettive, Sapienza, Università di Roma, 00161 Roma, Italy.

Sabrina Mariotti (S)

Dipartimento di Malattie Infettive, Istituto Superiore di Sanità, 00161 Roma, Italy.

Roberto Nisini (R)

Dipartimento di Malattie Infettive, Istituto Superiore di Sanità, 00161 Roma, Italy.

Raffaele D'Amelio (R)

Dipartimento di Medicina Clinica e Molecolare, Sapienza, Università di Roma, 00198 Roma, Italy.

Classifications MeSH